Dr. Yu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
160 E 34th St
New York, NY 10016Phone+1 212-731-6120
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2018 - 2021- University of Pennsylvania Health SystemResidency, Internal Medicine, 2014 - 2017
Albert Einstein College of MedicineClass of 2014
Columbia University in the City of New YorkBiomedical Engineering, Summa Cum Laude, 2005 - 2009
Certifications & Licensure
NY State Medical License 2021 - 2026
PA State Medical License 2014 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 66 citationsA Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal AdenocarcinomaEugene J. Koay, Yeonju Lee, Vittorio Cristini, John Lowengrub, Ya'an Kang
Clinical Cancer Research. 2018-12-01 - 124 citationsPlatinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation.Max M. Wattenberg, Daniella Asch, Shun Yu, Peter J. O'Dwyer, Susan M. Domchek
British Journal of Cancer. 2020-02-01 - 2 citationsA Natural Language Processing-Assisted Extraction System for Gleason Scores: Development and Usability Study.Shun Yu, Anh D. Le, Emily Feld, Emily Schriver, Peter Gabriel
JMIR Cancer. 2021-07-02
Journal Articles
- A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal AdenocarcinomaShun Yu, Deyali Chatterjee, Rong Ye, Prajnan Das, Naveen Garg, Robert A Wolff, Huamin Wang, Eugene J Koay, Gauri R Varadhachary, Christopher H Crane, Milind Javle, Jef..., Clinical Cancer Research
Press Mentions
Gastrointestinal Chemotherapy Tweak Can Reduce Side EffectsSeptember 6th, 2024- Study Backs Skipping 5-FU Bolus in Chemo Regimens for Gastrointestinal CancersSeptember 5th, 2024
- New Study in JNCCN Supports Chemotherapy Option That Reduces Side Effects for People with Gastrointestinal CancersSeptember 5th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
